FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer whose disease…
Oncology
Managing delirium in hospitalized older adults
Lawrence Jeffries, age 78, is admitted to the hospital for an arthroplasty of the left hip. A retired roofer, he lives with his wife…
From our readers: One patient’s story
Eric’s* storytelling made a difference in my nursing practice. Eric was a 27-year-old African American patient with end-stage renal disease (ESRD), who was admitted…
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with…
Certain subtypes of delirium may signal end of life for terminally ill patients with cancer
Hypoactive and mixed delirium in patients with cancer who are nearing the end of life indicate “imminent death,” according to a study in in…
Preventing medication errors by empowering patients
Preventable medication errors cost the U.S. healthcare system more than $21 billion annually, according to the National Priorities Partnership and National Quality Forum. This…
The mindful nurse
Mindfulness is an increasingly common topic in both popular and professional literature. In clinical populations, evidence suggests mindfulness-based interventions (MBIs) can reduce symptoms linked…
Keeping nurses healthy, safe, and well
To keep patients healthy, safe, and well, registered nurses (RNs) have to be healthy, safe, and well themselves. Yet RNs face health, safety, and…
Quiz time – 8/18/15
Which statement about a tumor’s hormone-receptor and HER2 status is correct? a. Hormone-receptor status refers to the degree to which estrogen receptors in the tumor…
From our readers: When your parent is the patient
It’s not easy when your parent is the patient. In my 10 years of being a registered nurse, I have learned a lot, seen…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer…
Managing delirium in hospitalized older adults
Lawrence Jeffries, age 78, is admitted to the hospital for an arthroplasty of the left hip. A retired roofer, he lives with…
From our readers: One patient’s story
Eric’s* storytelling made a difference in my nursing practice. Eric was a 27-year-old African American patient with end-stage renal disease (ESRD), who…
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for…
Certain subtypes of delirium may signal end of life for terminally ill patients with cancer
Hypoactive and mixed delirium in patients with cancer who are nearing the end of life indicate “imminent death,” according to a study…
Preventing medication errors by empowering patients
Preventable medication errors cost the U.S. healthcare system more than $21 billion annually, according to the National Priorities Partnership and National Quality…
The mindful nurse
Mindfulness is an increasingly common topic in both popular and professional literature. In clinical populations, evidence suggests mindfulness-based interventions (MBIs) can reduce…
Keeping nurses healthy, safe, and well
To keep patients healthy, safe, and well, registered nurses (RNs) have to be healthy, safe, and well themselves. Yet RNs face health,…
Quiz time – 8/18/15
Which statement about a tumor’s hormone-receptor and HER2 status is correct? a. Hormone-receptor status refers to the degree to which estrogen receptors in…
From our readers: When your parent is the patient
It’s not easy when your parent is the patient. In my 10 years of being a registered nurse, I have learned a…
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.